You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 19, 2024

CLINICAL TRIALS PROFILE FOR SYNDROS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for syndros

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03661892 ↗ Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets Completed University of Arizona Early Phase 1 2018-12-19 In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
NCT04346407 ↗ Dronabinol for Post-operative Pain After Lumbar Fusion Enrolling by invitation Jeffrey L Gum MD Phase 4 2020-09-01 Impact of 2.5mg of oral Dronabinol daily versus placebo on post-operative opioid consumption on patients aged 18 to 65 years old undergoing 1 to 3 level posterolateral fusion
NCT06034314 ↗ Oral Dronabinol-HIV Recruiting National Institute on Drug Abuse (NIDA) Phase 1 2023-09-21 The purpose of this study is to define the mechanisms of cannabis on the genome of people with HIV who use cannabis. The investigator aims to better understand the effect of Dronabinol on immune and inflammatory functions, and whether these changes are HIV-status dependent. This research may better inform public health policy regarding cannabis use. Depending on the results, additional studies may also build upon this research to develop more effective and specific treatments for cannabis use associated disorders.
NCT06034314 ↗ Oral Dronabinol-HIV Recruiting Yale University Phase 1 2023-09-21 The purpose of this study is to define the mechanisms of cannabis on the genome of people with HIV who use cannabis. The investigator aims to better understand the effect of Dronabinol on immune and inflammatory functions, and whether these changes are HIV-status dependent. This research may better inform public health policy regarding cannabis use. Depending on the results, additional studies may also build upon this research to develop more effective and specific treatments for cannabis use associated disorders.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for syndros

Condition Name

Condition Name for syndros
Intervention Trials
Bone Metastases 1
Breast Cancer 1
HIV 1
Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for syndros
Intervention Trials
Pain, Postoperative 1
Neoplasm Metastasis 1
Breast Neoplasms 1
Bone Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for syndros

Trials by Country

Trials by Country for syndros
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for syndros
Location Trials
Connecticut 1
Kentucky 1
Arizona 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for syndros

Clinical Trial Phase

Clinical Trial Phase for syndros
Clinical Trial Phase Trials
Phase 4 1
Phase 1 1
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for syndros
Clinical Trial Phase Trials
Completed 1
Enrolling by invitation 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for syndros

Sponsor Name

Sponsor Name for syndros
Sponsor Trials
Yale University 1
University of Arizona 1
Jeffrey L Gum MD 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for syndros
Sponsor Trials
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.